Skip to main content

. 1996 Feb 17;312(7028):414–415. doi: 10.1136/bmj.312.7028.414

Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study.

K R Neal ¹, H M Scott ¹, R C Slack ¹, R F Logan ¹

PMCID: PMC2350063 PMID: 8601113

414

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Giannella R. A., Broitman S. A., Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut. 1972 Apr;13(4):251–256. doi: 10.1136/gut.13.4.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
Glynn J. R., Bradley D. J. The relationship between infecting dose and severity of disease in reported outbreaks of Salmonella infections. Epidemiol Infect. 1992 Dec;109(3):371–388. doi: 10.1017/s0950268800050366. [DOI] [PMC free article] [PubMed] [Google Scholar]
Neal K. R., Briji S. O., Slack R. C., Hawkey C. J., Logan R. F. Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection. BMJ. 1994 Jan 15;308(6922):176–176. doi: 10.1136/bmj.308.6922.176. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES